HRP Anti-ATP5A antibody [EPR13030(B)]

2 product images

• 

  Western blot - HRP Anti-ATP5A antibody [EPR13030(B)] (ab195891)

  This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 1% milk blocking buffer before being incubated with ab195891 overnight at 4°C. Antibody binding was visualised using ECL development solution ECL Substrate Kit (High Sensitivity) ab133406.

  All lanes: Western blot - HRP Anti-ATP5A antibody [EPR13030(B)] (ab195891) at 1/5000 dilution

  Lane 1: HepG2 Whole Cell Lysate at 10 µg

  Lane 2: ATCC HeLa Whole Cell Lysate at 10 µg

  Lane 3: Human Adult Liver Tissue Lysate at 10 µg

  Developed using the ECL technique.

  Performed under reducing conditions.

  Predicted band size: 60 kDa

  Observed band size: 55 kDa

  Exposure time: 2min

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - HRP Anti-ATP5A antibody [EPR13030(B)] (ab195891)

  IHC image of ATP5A staining in a section of formalin-fixed paraffin-embedded normal human liver tissue*, performed on a Leica BOND. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab195891 at 1/50 dilution, for 15 mins at room temperature. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset negative control image is taken from an identical assay without primary antibody.

  For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

  *Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre